The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Disseminated Intravascular Coagulation

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Disseminated Intravascular Coagulation


Psychiatry related information on Disseminated Intravascular Coagulation


High impact information on Disseminated Intravascular Coagulation


Chemical compound and disease context of Disseminated Intravascular Coagulation


Biological context of Disseminated Intravascular Coagulation


Anatomical context of Disseminated Intravascular Coagulation


Gene context of Disseminated Intravascular Coagulation


Analytical, diagnostic and therapeutic context of Disseminated Intravascular Coagulation


  1. Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. Anand, K.J., Hickey, P.R. N. Engl. J. Med. (1992) [Pubmed]
  2. Reversing systemic inflammatory response syndrome with chemokine receptor pepducins. Kaneider, N.C., Agarwal, A., Leger, A.J., Kuliopulos, A. Nat. Med. (2005) [Pubmed]
  3. Anaphylactic shock, acute renal failure, and disseminated intravascular coagulation. Suspected complications of zomepirac. Smith, V.T. JAMA (1982) [Pubmed]
  4. Disseminated intravascular coagulation in heat stroke. Response to heparin therapy. Perchick, J.S., Winkelstein, A., Shadduck, R.K. JAMA (1975) [Pubmed]
  5. Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. D'Angelo, A., Vigano-D'Angelo, S., Esmon, C.T., Comp, P.C. J. Clin. Invest. (1988) [Pubmed]
  6. Critically ill obstetric patients in an American and an Indian public hospital: comparison of case-mix, organ dysfunction, intensive care requirements, and outcomes. Munnur, U., Karnad, D.R., Bandi, V.D., Lapsia, V., Suresh, M.S., Ramshesh, P., Gardner, M.A., Longmire, S., Guntupalli, K.K. Intensive care medicine. (2005) [Pubmed]
  7. Plasma endothelin-1 levels in patients with disseminated intravascular coagulation. Ishibashi, M., Saito, K., Watanobe, K., Uesugi, S., Furue, H., Yamaji, T. N. Engl. J. Med. (1991) [Pubmed]
  8. Prolongation of a preterm pregnancy complicated by death of a single twin in utero and disseminated intravascular coagulation. Effects of treatment with heparin. Romero, R., Duffy, T.P., Berkowitz, R.L., Chang, E., Hobbins, J.C. N. Engl. J. Med. (1984) [Pubmed]
  9. Disseminated intravascular coagulation in prostatic carcinoma reversed by ketoconazole. Litt, M.R., Bell, W.R., Lepor, H.A. JAMA (1987) [Pubmed]
  10. Epinephrine exerts anticoagulant effects during human endotoxemia. van der Poll, T., Levi, M., Dentener, M., Jansen, P.M., Coyle, S.M., Braxton, C.C., Buurman, W.A., Hack, C.E., ten Cate, J.W., Lowry, S.F. J. Exp. Med. (1997) [Pubmed]
  11. Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life. Nagashima, M., Yin, Z.F., Zhao, L., White, K., Zhu, Y., Lasky, N., Halks-Miller, M., Broze, G.J., Fay, W.P., Morser, J. J. Clin. Invest. (2002) [Pubmed]
  12. Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulation. Giles, A.R., Nesheim, M.E., Mann, K.G. J. Clin. Invest. (1984) [Pubmed]
  13. Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management. Fisher-Hoch, S.P., Platt, G.S., Lloyd, G., Simpson, D.I., Neild, G.H., Barrett, A.J. Lancet (1983) [Pubmed]
  14. Coagulation changes during second-trimester abortion induced by intra-amniotic prostaglandin E2 and hypertonic solutions. MacKenzie, I.Z., Sayers, L., Bonnar, J., Hillier, K. Lancet (1975) [Pubmed]
  15. Letter: Coumadin-induced necrosis of breast, disseminated intravascular coagulation, and hemolytic anemia. DiCato M-A, n.u.l.l., Ellman, L. Ann. Intern. Med. (1975) [Pubmed]
  16. Letter: Isoniazid and disseminated intravascular coagulation. Stuart, J.J., Roberts, H.R. Ann. Intern. Med. (1976) [Pubmed]
  17. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. Kirchhofer, D., Tschopp, T.B., Hadváry, P., Baumgartner, H.R. J. Clin. Invest. (1994) [Pubmed]
  18. Sporadic cases of Legionnaires' disease: the expanding clinical spectrum. Gregory, D.W., Schaffner, W., Alford, R.H., Kaiser, A.B., McGee, Z.A. Ann. Intern. Med. (1979) [Pubmed]
  19. Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model. Hu, Z., Sun, Y., Garen, A. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  20. Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function. Samis, J.A., Kam, E., Nesheim, M.E., Giles, A.R. Blood (1998) [Pubmed]
  21. Plasma vitronectin polymorphism in normal subjects and patients with disseminated intravascular coagulation. Conlan, M.G., Tomasini, B.R., Schultz, R.L., Mosher, D.F. Blood (1988) [Pubmed]
  22. Retinoic acid selectively inhibits lipopolysaccharide induction of tissue factor gene expression in human monocytes. Oeth, P., Yao, J., Fan, S.T., Mackman, N. Blood (1998) [Pubmed]
  23. Hematin: unique effects of hemostasis. Glueck, R., Green, D., Cohen, I., Ts'ao, C.H. Blood (1983) [Pubmed]
  24. All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells. Koyama, T., Hirosawa, S., Kawamata, N., Tohda, S., Aoki, N. Blood (1994) [Pubmed]
  25. Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats. Fujita, M., Izutani, W., Komurasaki, Y. Thromb. Haemost. (2000) [Pubmed]
  26. Severe inherited "homozygous" protein C deficiency in a newborn infant. Estellés, A., Garcia-Plaza, I., Dasí, A., Aznar, J., Duart, M., Sanz, G., Pérez-Requejo, J.L., España, F., Jimenez, C., Abeledo, G. Thromb. Haemost. (1984) [Pubmed]
  27. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Ono, T., Mimuro, J., Madoiwa, S., Soejima, K., Kashiwakura, Y., Ishiwata, A., Takano, K., Ohmori, T., Sakata, Y. Blood (2006) [Pubmed]
  28. Prothrombinase enhancement through quantitative and qualitative changes affecting very low density lipoprotein in complex with C-reactive protein. Dennis, M.W., Downey, C., Brufatto, N., Nesheim, M.E., Stevenson, K., Toh, C.H. Thromb. Haemost. (2004) [Pubmed]
  29. Effects of intravenous infusion of human prostate tissue substances in dogs. O'Donnell, P.D. Prostate (1990) [Pubmed]
  30. Protein C pathway in infants and children. Petäjä, J., Manco-Johnson, M.J. Semin. Thromb. Hemost. (2003) [Pubmed]
  31. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience. de Jonge, E., van der Poll, T., Kesecioglu, J., Levi, M. Semin. Thromb. Hemost. (2001) [Pubmed]
  32. A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia. Fenaux, P., Tertian, G., Castaigne, S., Tilly, H., Leverger, G., Guy, H., Bordessoule, D., Leblay, R., Le Gall, E., Colombat, P. J. Clin. Oncol. (1991) [Pubmed]
  33. Variation in activities of non-plasmin fibrinolytic proteinase and plasminogen-activator in the lung and spleen induced by bacterial endotoxin in rats with special reference to the effects of MD-805. Okamoto, U., Nagamatsu, Y., Horie, N., Yamamoto, J., Sasaki, K. Thromb. Haemost. (1985) [Pubmed]
  34. Fluctuations in plasma levels of thrombomodulin in patients with DIC. Amano, K., Tateyama, M., Inaba, H., Fukutake, K., Fujimaki, M. Thromb. Haemost. (1992) [Pubmed]
  35. Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation? Nishiyama, T., Matsukawa, T., Hanaoka, K. Crit. Care Med. (2000) [Pubmed]
  36. Heparin management for cardiopulmonary bypass in a patient with disseminated intravascular coagulation. Janda, A., Salem, C., Berger, M., Kubiena, K., Fischer, M. Anesthesiology (1988) [Pubmed]
WikiGenes - Universities